Publications

You can use the filters to show only results that match your interests

Filter publications
352 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences for manufacturers and wholesalers of medicines

  2. Strategy for pharmacopoeial public quality standards for biological medicines

    • MHRA
    • Consultation outcome
  3. Marketing authorisations granted in September 2017

  4. Parallel import licenses granted in September 2017

  5. Human and veterinary medicines: register of licensed wholesale distribution sites

  6. Register of brokers authorised to deal in human medicines

  7. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  8. Medicines: new manufacturing and wholesale dealer licences

  9. Devices which incorporate an ancillary medicinal substance

  10. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  11. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  12. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  13. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  14. Medical devices: software applications (apps)

  15. Marketing authorisations granted in August 2017

  16. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  17. Advertising investigations: August 2017

  18. Guidance on applying human factors to medical devices

    • MHRA
    • Guidance
  19. Parallel import licenses granted in August 2017

  20. Human and veterinary medicines: register of licensed manufacturing sites 2017

  21. Toolkit on the risks of valproate medicines in female patients

  22. Early access to medicines scheme (EAMS) scientific opinion: Alectinib as monotherapy for the first-line treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC)

  23. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Consultation outcome
  24. MHRA: business impact target

    • MHRA
    • Research and analysis
  25. Marketing authorisations granted in July 2017

  26. Parallel import licences granted in July 2017

  27. Widening the availability of naloxone

    • DH, MHRA and PHE
    • Guidance
  28. Human Medicines Regulations 2012 Advisory Bodies annual report 2016

    • MHRA
    • Corporate report
  29. Good clinical practice inspection metrics

  30. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2016 to 2017

    • MHRA
    • Corporate report
  31. Proposal to make Arthriex 750mg and 1500mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  32. Marketing authorisations granted in June 2017

  33. Parallel import licenses granted in June 2017

  34. Classification of Nasonex Allergy Control Nasal Spray

    • MHRA
    • Consultation outcome
  35. Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

    • MHRA
    • Consultation outcome
  36. Proposal to make Maloff Protect 250mg/100mg film-coated tablets available from Pharmacies

    • MHRA
    • Consultation outcome
  37. Notified bodies for medical devices

  38. Medical devices: UK notified bodies

  39. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  40. Better consultations, better evidence

    • MHRA
    • Research and analysis